Two decades of commitment to quality, affordability, and patient-centered healthcare from the heart of Uttarakhand.
The driving force behind Amro Pharmaceuticals is Mr. Rajiv Khanna β a seasoned pharmaceutical professional with over four decades of experience in the highly competitive Indian pharma industry. Beginning his journey as a Medical Representative, he travelled extensively across the country, gaining deep insight into the pharmaceutical landscape, market dynamics, and the doctor-patient ecosystem.
His early years in the field shaped a strong understanding of sales, distribution, and relationship-building β values that continue to define the company today. After nearly a decade of hands-on industry experience, he ventured into entrepreneurship, successfully building businesses across pharmacies and pharmaceutical brands.
over two decades back, with a focused vision towards pharmaceutical marketing and sales, Mr. Rajiv Khanna laid the foundation of Amro Pharmaceuticals in Dehradun β choosing a city that would become the company's anchor as it expanded across India.
Today, as the company completes over two decades in the industry, Amro continues to grow with the same commitment to quality, trust, and ethical healthcare practices that it was built upon.
The next chapter of Amro's journey is being shaped by the entry of Aryan Khanna as Marketing Head β bringing fresh perspective, renewed ambition, and a deep passion for expanding the brand to national heights while carrying forward its foundational values of trust and integrity.
With 40+ years in pharmaceuticals, Rajiv leads overall corporate governance, quality audit regulations, and ethical partnerships.
Aryan leads our national business expansion, distributor network digital integration, and franchise support programs.
Directs our extensive catalog formulation quality controls, chemical research compliance, and inventory logistics.
To make dependable healthcare more accessible by delivering thoughtfully selected pharmaceutical products that combine quality, affordability, and trust β while nurturing strong relationships with doctors, distributors, and patients through ethical practices, heavy research, and consistent support.
To build Amro Pharmaceuticals into a trusted national healthcare brand that grows through credibility, meaningful partnerships, and a deep understanding of everyday medical needs β creating a lasting impact across communities we serve.
Mr. Rajiv Khanna established Amro Pharmaceuticals in Dehradun over two decades back, with a focused vision towards pharmaceutical marketing and sales.
Launched 10β15 diverse pharmaceutical products across multiple therapeutic categories, establishing a steady presence in the regional market.
Became a recognised and major name across India, building strong relationships with healthcare professionals and distributors nationwide.
Product portfolio grew to 35 formulations spanning analgesics, CNS drugs, ayurvedics, nutraceuticals, antacids, and more β reflecting growing patient and market needs.
With Aryan Khanna joining as Marketing Head and Rajendra Goja as Product Manager, Amro embarks on a national expansion drive β widening its portfolio and geographic footprint to become a trusted pan-India healthcare brand.
Key details about our corporate origins, clinical standards, and executive management team.
Amro Pharmaceuticals was established over two decades back by Mr. Rajiv Khanna. We have over two decades of corporate trust and active B2B presence in marketing and distributing essential medicines across India.
Amro Pharmaceuticals is led by Founder & Director Mr. Rajiv Khanna, who has over 40 years of core industry experience. The next-generation marketing and distribution expansion is spearheaded by Aryan Khanna (Marketing Head), alongside Rajendra Goja (Product Manager) supervising quality audits.
Absolutely! Amro is a strict quality-focused marketing brand. We exclusively source our product catalog from WHO-GMP compliant, certified manufacturing labs. This ensures that every tablet, capsule, and herbal extract complies with strict Schedule M drug audit guidelines before reaching consumers.